Business Monitor International Launches Report on China's Pharmaceutical and Healthcare Industry

LONDON, May 19, 2011 - Business Monitor International (BMI) has announced its latest report,
China Pharmaceuticals & Healthcare Report.

The healthcare and pharmaceutical analysis
(analysis.businessmonitor.com/intelligence/all-regions/all-countries/pharmaceuticals-healthcare)
includes Business Monitor International's five and ten year forecast for
drugs and healthcare expenditure, imports and exports, and focuses on the
growth outlook for the prescription, OTC, patented drugs and generics market
segments. The forecasts are based on in depth analysis into industry trends
and new developments.

The China Analysis
(analysis.businessmonitor.com/intelligence/asia/china/all-industries)
report is designed to provide industry professionals, market investors and
corporate and financial services analysts with independent forecasts and
competitive intelligence on the Chinese pharmaceutical and healthcare
industry. The report is vital to these groups so that they can benchmark
BMI's independent five and ten year pharmaceutical and healthcare industry
forecasts on China, target business opportunities and risks in the Chinese
pharmaceutical and healthcare sector and assess the activities, strategy and
market position of pharmaceutical competitors, partners and clients.

Following the outcome of Q1 2011, BMI now predicts China will become the
most attractive pharmaceutical market in Asia Pacific within the next five
years. China has the world's most attractive emerging pharmaceutical market.
Driven by a booming economy and underpinned by political stability, demand
for medicines, both generic and patented, will continue to increase. However
- the key downside risk is further pricing pressures, which could intensify
in the event of an economic slowdown.

About Business Monitor International
(analysis.businessmonitor.com/):

Business Monitor International (BMI) is a leading, independent provider
of proprietary data, industry reports
(analysis.businessmonitor.com/intelligence/all-regions/all-countries/all-industries)
ratings, rankings and forecasts covering 175 countries and 22
industry sectors.

BMI's customers and clients span more than 140 countries worldwide,
including more than 400 of the Global Fortune 500 companies. Businesses,
banks, financial service companies, governments, academia and research
centres have all come to rely on BMI's analysis, data and forecasts - and
have done so for 25 years. The company was awarded the Queen's Award for
Export Achievement in 1997.

BMI is a wholly independent company, headquartered at Blackfriars,
London, with foreign offices in Singapore and New York.

BMI's corporate mission is to become the world's No.1 Independent
Information Provider in its field (Country Risk & Industry Research).

Business Monitor International was founded in 1984 by Richard
Londesborough and Jonathan Feroze, the company's joint CEOs, who both
continue to play a full role within the company.

(Due to the lengths of the above URLs, it may be necessary to copy and
paste these hyperlinks into your Internet browser's URL address field.
Remove the space if one exists.)

    PR contact:

    Matthew Brooks
    Head of Strategic Analysis & Product Development
    Mermaid House
    2 Puddle Dock
    London
    EC4V 3DS
    United Kingdom
    +44(0)20-7248-0468

analysis.businessmonitor.com

.